Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

Correction to: Invest New Drugs

Table 2.

Univariate analysis of variables associated with Gr 2 pneumonitis

Variables		Odds ratio	p value
Age (years)	≥70 vs. <70	2.500	0.237
Sex	Male vs. Female	0.333	0.163
Pathological type	Adeno vs. Squamous	0.486	0.343
Location	Lower lobe vs. Upper lobe	2.250	0.305
Smoking history	Yes vs. No	0.257	0.148
Baseline pneumonitis	Yes vs. No	0.500	0.470
Radiation	Proton beam vs. X-ray	3.889	0.148
Facility	Our institution vs. others	0.524	0.517
V20	≥26 vs. <26	2.250	0.305
V20 (continuous)		1.047	0.303

10.1007/s10637-020-00917-2

Corrections are needed to the original version of this article. In Table 2, the “Odds ratio” of the variables “Lower lobe vs. Upper lobe” and “≥26 vs. <26” should be 2.250 instead of 2250 and 2.250 instead of 2.25.

The authors apologize for the corrections and further state that the changes does not affect the overall outcome of the study.

The corrected Table 2 is shown below: